These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9815935)
1. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325 [TBL] [Abstract][Full Text] [Related]
4. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]. Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Zenklusen JC; Thompson JC; Troncoso P; Kagan J; Conti CJ Cancer Res; 1994 Dec; 54(24):6370-3. PubMed ID: 7987830 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271 [TBL] [Abstract][Full Text] [Related]
7. A molecular cytogenetic analysis of 7q31 in prostate cancer. Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032 [TBL] [Abstract][Full Text] [Related]
8. Differential chromosome allelic imbalance in the progression of human prostate cancer. Latil A; Fournier G; Cussenot O; Lidereau R J Urol; 1996 Dec; 156(6):2079-83. PubMed ID: 8911394 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Takahashi S; Shan AL; Ritland SR; Delacey KA; Bostwick DG; Lieber MM; Thibodeau SN; Jenkins RB Cancer Res; 1995 Sep; 55(18):4114-9. PubMed ID: 7664288 [TBL] [Abstract][Full Text] [Related]
10. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Zenklusen JC; Thompson JC; Klein-Szanto AJ; Conti CJ Cancer Res; 1995 Mar; 55(6):1347-50. PubMed ID: 7882334 [TBL] [Abstract][Full Text] [Related]
11. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281 [TBL] [Abstract][Full Text] [Related]
12. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer. Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610 [TBL] [Abstract][Full Text] [Related]
13. Genetic alteration mapping on chromosome 7 in primary breast cancer. Bièche I; Khodja A; Driouch K; Lidereau R Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778 [TBL] [Abstract][Full Text] [Related]
14. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer. Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310 [TBL] [Abstract][Full Text] [Related]
16. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419 [TBL] [Abstract][Full Text] [Related]
17. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322 [TBL] [Abstract][Full Text] [Related]
18. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204 [TBL] [Abstract][Full Text] [Related]
19. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]